NM_001127222.2:c.6266G>C

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_001127222.2(CACNA1A):​c.6266G>C​(p.Arg2089Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,461,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2089W) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

8
9
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 4.69

Publications

0 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.843

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.6266G>C p.Arg2089Pro missense_variant Exon 43 of 47 ENST00000360228.11 NP_001120694.1
CACNA1ANM_001127221.2 linkc.6269G>C p.Arg2090Pro missense_variant Exon 43 of 47 ENST00000638009.2 NP_001120693.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.6266G>C p.Arg2089Pro missense_variant Exon 43 of 47 1 NM_001127222.2 ENSP00000353362.5
CACNA1AENST00000638009.2 linkc.6269G>C p.Arg2090Pro missense_variant Exon 43 of 47 1 NM_001127221.2 ENSP00000489913.1
CACNA1AENST00000638029.1 linkc.6284G>C p.Arg2095Pro missense_variant Exon 44 of 48 5 ENSP00000489829.1
CACNA1AENST00000573710.7 linkc.6272G>C p.Arg2091Pro missense_variant Exon 43 of 47 5 ENSP00000460092.3
CACNA1AENST00000635727.1 linkc.6269G>C p.Arg2090Pro missense_variant Exon 43 of 47 5 ENSP00000490001.1
CACNA1AENST00000637769.1 linkc.6269G>C p.Arg2090Pro missense_variant Exon 43 of 47 1 ENSP00000489778.1
CACNA1AENST00000636012.1 linkc.6269G>C p.Arg2090Pro missense_variant Exon 43 of 46 5 ENSP00000490223.1
CACNA1AENST00000637736.1 linkc.6128G>C p.Arg2043Pro missense_variant Exon 42 of 46 5 ENSP00000489861.1
CACNA1AENST00000636389.1 linkc.6269G>C p.Arg2090Pro missense_variant Exon 43 of 47 5 ENSP00000489992.1
CACNA1AENST00000637432.1 linkc.6284G>C p.Arg2095Pro missense_variant Exon 44 of 48 5 ENSP00000490617.1
CACNA1AENST00000636549.1 linkc.6275G>C p.Arg2092Pro missense_variant Exon 44 of 48 5 ENSP00000490578.1
CACNA1AENST00000637927.1 linkc.6272G>C p.Arg2091Pro missense_variant Exon 43 of 47 5 ENSP00000489715.1
CACNA1AENST00000635895.1 linkc.6269G>C p.Arg2090Pro missense_variant Exon 43 of 47 5 ENSP00000490323.1
CACNA1AENST00000637276.1 linkc.6269G>C p.Arg2090Pro missense_variant Exon 43 of 46 5 ENSP00000489777.1
CACNA1AENST00000636768.2 linkn.*568G>C non_coding_transcript_exon_variant Exon 42 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.*1481G>C non_coding_transcript_exon_variant Exon 44 of 47 ENSP00000519091.1
CACNA1AENST00000636768.2 linkn.*568G>C 3_prime_UTR_variant Exon 42 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.*1481G>C 3_prime_UTR_variant Exon 44 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461288
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
726954
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33470
American (AMR)
AF:
0.00
AC:
0
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53278
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111634
Other (OTH)
AF:
0.00
AC:
0
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.68
BayesDel_addAF
Pathogenic
0.25
D
BayesDel_noAF
Uncertain
0.12
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Benign
0.16
.;.;T;.;.;.;.;.;T;.;.;T;.;.;.;T;.;.
Eigen
Uncertain
0.56
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Pathogenic
0.99
D;D;D;D;D;D;D;D;D;D;.;D;D;D;D;D;D;D
M_CAP
Pathogenic
0.56
D
MetaRNN
Pathogenic
0.84
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.37
D
MutationAssessor
Pathogenic
3.1
.;.;.;.;M;.;.;.;.;.;.;.;.;.;M;.;.;.
PhyloP100
4.7
PrimateAI
Uncertain
0.66
T
PROVEAN
Pathogenic
-6.6
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Pathogenic
0.71
Sift
Uncertain
0.0020
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Uncertain
0.010
D;D;.;.;.;D;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.91
MutPred
0.36
.;.;Loss of MoRF binding (P = 0.0093);Loss of MoRF binding (P = 0.0093);Loss of MoRF binding (P = 0.0093);.;.;Loss of MoRF binding (P = 0.0093);.;.;.;Loss of MoRF binding (P = 0.0093);Loss of MoRF binding (P = 0.0093);.;Loss of MoRF binding (P = 0.0093);.;.;.;
MVP
0.83
MPC
0.85
ClinPred
0.99
D
GERP RS
3.4
Varity_R
0.85
gMVP
0.73
Mutation Taster
=55/45
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1033214914; hg19: chr19-13322954; API